Department of Radiology
Found 16 results
Filters: Keyword is Phosphorylation  [Clear All Filters]
2023
Martinez-Lopez N, Mattar P, Toledo M, Bains H, Kalyani M, Aoun MLouise, Sharma M, McIntire LBeth J, Gunther-Cummins L, Macaluso FP et al..  2023.  mTORC2-NDRG1-CDC42 axis couples fasting to mitochondrial fission.. Nat Cell Biol. 25(7):989-1003.
2016
Spiegel J, Pirraglia E, Osorio RS, Glodzik L, Li Y, Tsui W, Louis LASaint, Randall C, Butler T, Xu J et al..  2016.  Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.. J Alzheimers Dis. 49(1):93-100.
Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, Tweardy S, Lewis C, Fischer E, Koushyk V et al..  2016.  Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.. Sleep. 39(6):1253-60.
2015
Yu Y, Li X, Blanchard J, Li Y, Iqbal K, Liu F, Gong C-X.  2015.  Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice.. J Neural Transm (Vienna). 122(4):593-606.
2014
Glodzik L, Rusinek H, Pirraglia E, McHugh P, Tsui W, Williams S, Cummings M, Li Y, Rich K, Randall C et al..  2014.  Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.. Neurobiol Aging. 35(1):64-71.
Duits FH, Teunissen CE, Bouwman FH, Visser P-J, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N et al..  2014.  The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement. 10(6):713-723.e2.
2013
Alonso Adel Carmen, ElAkkad E, Gong CX, Liu F, Tanaka T, Kudo T, Tatebayashi Y, Pei JJ, Wang JZ, Khatoon S et al..  2013.  Inge Grundke-Iqbal, Ph.D. (1937–2012): the discoverer of the abnormal hyperphosphorylation of tau in Alzheimer’s disease.. J Mol Neurosci. 49(2):430-5.
2011
Glodzik L, de Santi S, Tsui WHon, Mosconi L, Zinkowski R, Pirraglia E, Wang HYu, Li Y, Rich KE, Zetterberg H et al..  2011.  Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.. Neurobiol Aging. 32(12):2131-41.
Kim HNa, Kim H, Kong JMyung, Bae S, Kim YSung, Lee N, Cho BJoo, Lee SKoo, Kim H-R, Hwang Y-il et al..  2011.  Vitamin C down-regulates VEGF production in B16F10 murine melanoma cells via the suppression of p42/44 MAPK activation.. J Cell Biochem. 112(3):894-901.
2009
Yu Y, Run X, Liang Z, Li Y, Liu F, Liu Y, Iqbal K, Grundke-Iqbal I, Gong C-X.  2009.  Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases.. J Neurochem. 108(6):1480-94.
Glodzik L, de Santi S, Rich KE, Brys M, Pirraglia E, Mistur R, Switalski R, Mosconi L, Sadowski M, Zetterberg H et al..  2009.  Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology.. J Alzheimers Dis. 18(3):509-13.
Glodzik-Sobanska L, Pirraglia E, Brys M, de Santi S, Mosconi L, Rich KE, Switalski R, Louis LSaint, Sadowski MJ, Martiniuk F et al..  2009.  The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.. Neurobiol Aging. 30(5):672-81.
2008
Wegiel J, Dowjat K, Kaczmarski W, Kuchna I, Nowicki K, Frackowiak J, Kolecka BMazur, Wegiel J, Silverman WP, Reisberg B et al..  2008.  The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.. Acta Neuropathol. 116(4):391-407.
2007
Mosconi L, Tsui WH, Rusinek H, de Santi S, Li Y, Wang G-J, Pupi A, Fowler J, de Leon MJ.  2007.  Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease.. Eur J Nucl Med Mol Imaging. 34(9):1467-79.
1994
Jeitner TM, Kneale CL, Christopherson RI, Hunt NH.  1994.  Thiol-bearing compounds selectively inhibit protein kinase C-dependent oxidative events and proliferation in human T cells.. Biochim Biophys Acta. 1223(1):15-22.
1989
Marcus DL, de Leon MJ, Goldman J, Logan J, Christman DR, Wolf AP, Fowler JS, Hunter K, Tsai J, Pearson J.  1989.  Altered glucose metabolism in microvessels from patients with Alzheimer's disease.. Ann Neurol. 26(1):91-4.